SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-331813
Filing Date
2021-11-17
Accepted
2021-11-17 06:06:57
Documents
14
Period of Report
2021-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257656d8k.htm   iXBRL 8-K 23705
2 EX-99.1 d257656dex991.htm EX-99.1 13220
6 GRAPHIC g257656g1117051438461.jpg GRAPHIC 2613
  Complete submission text file 0001193125-21-331813.txt   165309

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA biib-20211115.xsd EX-101.SCH 2899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20211115_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20211115_pre.xml EX-101.PRE 10958
7 EXTRACTED XBRL INSTANCE DOCUMENT d257656d8k_htm.xml XML 3210
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 211418356
SIC: 2836 Biological Products, (No Diagnostic Substances)